JAC Advance Access published online on August 27, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn334
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element
1 Department of Microbiology, University of Ghana Medical School, PO Box 4236, Accra, Ghana 2 Department of Biology, Haverford College, 370 Lancaster Avenue, Haverford, PA 19041, USA
Received 16 May 2008; returned 16 June 2008; revised 24 July 2008; accepted 25 July 2008
* Corresponding author. Tel: +1-610-896-1470; Fax: +1-610-896-4963; E-mail: iokeke{at}haverford.edu
Objectives: Vibrio cholerae O1 from a 2006 outbreak in Accra were commonly resistant to multiple antimicrobials and, in particular, to trimethoprim/sulfamethoxazole, drugs commonly used in the treatment of cholera. We sought to determine the genetic basis for trimethoprim/sulfamethoxazole resistance in outbreak isolates.
Methods: Twenty-seven isolates from the outbreak were screened by PCR and sequencing for class 1 and 2 integrons and for the SXT element.
Results: Twenty-one of the 27 isolates examined, all from the Accra metropolitan area, carried both SXT, an integrated chromosomal element, and a class 2 integron bearing dfrA1, sat and aadA1 cassettes. All these isolates had identical random amplification of polymorphic DNA profiles and two of them also carried a class 1 integron.
Conclusions: Most strains characterized carried multiple elements conferring resistance to trimethoprim. This suggests that trimethoprim/sulfamethoxazole should not be used empirically in cholera treatment.
Key Words: trimethoprim resistance , antimicrobial resistance , antibiotic resistance , cholera